These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7814291)

  • 1. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Ashton RJ; Abbott KH; Smith GM; Sutton D
    J Antimicrob Chemother; 1994 Aug; 34(2):287-90. PubMed ID: 7814291
    [No Abstract]   [Full Text] [Related]  

  • 2. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
    Thackray AM; Field HJ
    J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
    Thackray AM; Field HJ
    J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
    Field HJ; Tewari D; Sutton D; Thackray AM
    Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency.
    Field HJ; Thackray AM
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):461-70. PubMed ID: 10772727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famciclovir safe and effective for herpes.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successors to acyclovir.
    Easterbrook P; Wood MJ
    J Antimicrob Chemother; 1994 Sep; 34(3):307-11. PubMed ID: 7829405
    [No Abstract]   [Full Text] [Related]  

  • 12. Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.
    Smith DE; Gold J
    Sex Health; 2007 Jun; 4(2):141-2. PubMed ID: 17524295
    [No Abstract]   [Full Text] [Related]  

  • 13. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
    Thackray AM; Field HJ
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of famciclovir and valaciclovir in the treatment of viral keratitis.
    Gatchel S
    Clin Infect Dis; 1996 May; 22(5):886. PubMed ID: 8722973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives for the treatment and prevention of herpes simplex infections].
    Snoeck R
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):662-5. PubMed ID: 12122338
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the treatment of herpesvirus infection: the role of famciclovir.
    Tyring SK
    Clin Ther; 1998; 20(4):661-70. PubMed ID: 9737826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment.
    Thackray AM; Field HJ
    J Gen Virol; 2000 Oct; 81(Pt 10):2385-2396. PubMed ID: 10993926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
    Gagyor I; Madhok VB; Daly F; Somasundara D; Sullivan M; Gammie F; Sullivan F
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001869. PubMed ID: 26343420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.